ArticleBiodegradation2026
Biodegradation of ethanol and acetaldehyde by Lactiplantibacillus plantarum YDL-01 from healthy human feces.
Article in Biodegradation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Excessive alcohol intake triggers a series of systemic health hazards through the accumulation of acetaldehyde, a major carcinogen that poses a severe threat to human health. Here, a promising probiotic bacterial strain capable of biodegrading both ethanol and acetaldehyde was successfully isolated from healthy human feces and identified as Lactiplantibacillus plantarum YDL-01. In vitro assays demonstrated that an initial concentration of 5.0 g/L of ethanol or acetaldehyde could be completely biodegraded within 72 h or 16 h, respectively, by whole cells or cell-free extracts (CEs) of YDL-01, indicating that YDL-01 possesses a strong capacity for the biodegradation of both compounds. Whole-genome sequencing revealed the key genes responsible for alcohol metabolism in YDL-01, elucidating a complete catabolic pathway: ethanol is initially converted to acetaldehyde, catalyzed by alcohol dehydrogenase (ADH, EC 1.1.1.1), and acetaldehyde is further transformed into acetic acid via aldehyde dehydrogenase (ALDH, EC 1.2.1.10). In vitro safety assessments confirmed that YDL-01 exhibits no hemolytic activity and lacks amino acid decarboxylase activities, preliminarily verifying its biosafety, which is critical for the development of functional foods or biotherapeutic products for ethanol and acetaldehyde detoxification.
Indexed as
Identifiers
42766164What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.